vs
FIRSTSUN CAPITAL BANCORP（FSUN）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是FIRSTSUN CAPITAL BANCORP的1.9倍（$207.3M vs $110.0M），FIRSTSUN CAPITAL BANCORP净利率更高（19.6% vs -62.0%，领先81.6%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 6.9%）
FirstSun Capital Bancorp是一家总部位于美国的金融控股公司，提供商业及个人贷款、存款产品、财富管理、财资解决方案等全面的银行金融服务，主要面向美国区域市场的个人消费者、中小企业及企业客户。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
FSUN vs RARE — 直观对比
营收规模更大
RARE
是对方的1.9倍
$110.0M
净利率更高
FSUN
高出81.6%
-62.0%
两年增速更快
RARE
近两年复合增速
6.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $110.0M | $207.3M |
| 净利润 | $21.6M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | — | -54.7% |
| 净利率 | 19.6% | -62.0% |
| 营收同比 | — | 25.9% |
| 净利润同比 | -8.4% | 3.5% |
| 每股收益（稀释后） | $0.76 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSUNRARE
| Q1 26 | $110.0M | — | ||
| Q4 25 | $110.2M | $207.3M | ||
| Q3 25 | $107.3M | $159.9M | ||
| Q2 25 | $105.6M | $166.5M | ||
| Q1 25 | $96.2M | $139.3M | ||
| Q4 24 | $98.7M | $164.6M | ||
| Q3 24 | $98.2M | $139.5M | ||
| Q2 24 | $96.2M | $147.0M |
净利润FSUNRARE
| Q1 26 | $21.6M | — | ||
| Q4 25 | $24.8M | $-128.6M | ||
| Q3 25 | $23.2M | $-180.4M | ||
| Q2 25 | $26.4M | $-115.0M | ||
| Q1 25 | $23.6M | $-151.1M | ||
| Q4 24 | $16.4M | $-133.2M | ||
| Q3 24 | $22.4M | $-133.5M | ||
| Q2 24 | $24.6M | $-131.6M |
营业利润率FSUNRARE
| Q1 26 | — | — | ||
| Q4 25 | 29.0% | -54.7% | ||
| Q3 25 | 26.4% | -106.9% | ||
| Q2 25 | 31.2% | -64.8% | ||
| Q1 25 | 30.9% | -102.6% | ||
| Q4 24 | 20.4% | -74.3% | ||
| Q3 24 | 29.1% | -94.6% | ||
| Q2 24 | 32.3% | -79.1% |
净利率FSUNRARE
| Q1 26 | 19.6% | — | ||
| Q4 25 | 22.5% | -62.0% | ||
| Q3 25 | 21.6% | -112.8% | ||
| Q2 25 | 25.0% | -69.0% | ||
| Q1 25 | 24.5% | -108.5% | ||
| Q4 24 | 16.6% | -80.9% | ||
| Q3 24 | 22.8% | -95.7% | ||
| Q2 24 | 25.5% | -89.5% |
每股收益（稀释后）FSUNRARE
| Q1 26 | $0.76 | — | ||
| Q4 25 | $0.89 | $-1.28 | ||
| Q3 25 | $0.82 | $-1.81 | ||
| Q2 25 | $0.93 | $-1.17 | ||
| Q1 25 | $0.83 | $-1.57 | ||
| Q4 24 | $0.57 | $-1.34 | ||
| Q3 24 | $0.79 | $-1.40 | ||
| Q2 24 | $0.88 | $-1.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $413.7M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $-80.0M |
| 总资产 | $8.6B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FSUNRARE
| Q1 26 | $413.7M | — | ||
| Q4 25 | $652.6M | $421.0M | ||
| Q3 25 | $659.9M | $202.5M | ||
| Q2 25 | $785.1M | $176.3M | ||
| Q1 25 | $621.4M | $127.1M | ||
| Q4 24 | $615.9M | $174.0M | ||
| Q3 24 | $573.7M | $150.6M | ||
| Q2 24 | $535.8M | $480.7M |
股东权益FSUNRARE
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $-80.0M | ||
| Q3 25 | $1.1B | $9.2M | ||
| Q2 25 | $1.1B | $151.3M | ||
| Q1 25 | $1.1B | $144.2M | ||
| Q4 24 | $1.0B | $255.0M | ||
| Q3 24 | $1.0B | $346.8M | ||
| Q2 24 | $996.6M | $432.4M |
总资产FSUNRARE
| Q1 26 | $8.6B | — | ||
| Q4 25 | $8.5B | $1.5B | ||
| Q3 25 | $8.5B | $1.2B | ||
| Q2 25 | $8.4B | $1.3B | ||
| Q1 25 | $8.2B | $1.3B | ||
| Q4 24 | $8.1B | $1.5B | ||
| Q3 24 | $8.1B | $1.5B | ||
| Q2 24 | $8.0B | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
经营现金流FSUNRARE
| Q1 26 | — | — | ||
| Q4 25 | $111.5M | $-99.8M | ||
| Q3 25 | $49.4M | $-91.4M | ||
| Q2 25 | $15.0M | $-108.3M | ||
| Q1 25 | $26.4M | $-166.5M | ||
| Q4 24 | $101.1M | $-79.3M | ||
| Q3 24 | $48.1M | $-67.0M | ||
| Q2 24 | $20.9M | $-77.0M |
自由现金流FSUNRARE
| Q1 26 | — | — | ||
| Q4 25 | $104.0M | $-100.8M | ||
| Q3 25 | $47.6M | $-92.7M | ||
| Q2 25 | $13.0M | $-110.7M | ||
| Q1 25 | $24.3M | $-167.8M | ||
| Q4 24 | $95.7M | $-79.5M | ||
| Q3 24 | $47.1M | $-68.6M | ||
| Q2 24 | $19.9M | $-79.0M |
自由现金流率FSUNRARE
| Q1 26 | — | — | ||
| Q4 25 | 94.3% | -48.6% | ||
| Q3 25 | 44.4% | -58.0% | ||
| Q2 25 | 12.3% | -66.5% | ||
| Q1 25 | 25.3% | -120.5% | ||
| Q4 24 | 97.0% | -48.3% | ||
| Q3 24 | 47.9% | -49.2% | ||
| Q2 24 | 20.6% | -53.7% |
资本支出强度FSUNRARE
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 0.5% | ||
| Q3 25 | 1.6% | 0.8% | ||
| Q2 25 | 1.9% | 1.5% | ||
| Q1 25 | 2.1% | 1.0% | ||
| Q4 24 | 5.5% | 0.1% | ||
| Q3 24 | 1.1% | 1.2% | ||
| Q2 24 | 1.1% | 1.4% |
现金转化率FSUNRARE
| Q1 26 | — | — | ||
| Q4 25 | 4.49× | — | ||
| Q3 25 | 2.13× | — | ||
| Q2 25 | 0.57× | — | ||
| Q1 25 | 1.12× | — | ||
| Q4 24 | 6.18× | — | ||
| Q3 24 | 2.15× | — | ||
| Q2 24 | 0.85× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FSUN
| Net Interest Income | $82.8M | 75% |
| Noninterest Income | $27.2M | 25% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
